We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+15.86%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$219M
AUM Growth
+$95.8M
(+78%)
Cap. Flow
+$80.7M
Cap. Flow
% of AUM
36.91%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
163
New
55
Increased
48
Reduced
23
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$32.3M |
| 2 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$3.42M |
| 3 |
TXNM
TXNM Energy Inc
TXNM
|
+$3.29M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$3.26M |
| 5 |
Indivior Pharmaceuticals
INDV
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$4.25M |
| 2 |
Coupang
CPNG
|
+$4.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
+$3.46M |
| 4 |
TGNA
TEGNA Inc
TGNA
|
+$2.44M |
| 5 |
First Horizon
FHN
|
+$2.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.57% |
| 2 | Technology | 13.44% |
| 3 | Communication Services | 5.29% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Rhythm Pharmaceuticals
RYTM
$7.95B
| – | – |
-35,478
| Closed | -$633K |
|
|
TGNA
152
DELISTED
TEGNA Inc
TGNA
| – | – |
-144,000
| Closed | -$2.44M |
|
153
T-Mobile US
TMUS
$191B
| – | – |
-2,310
| Closed | -$335K |
|
154
TransUnion
TRU
$15.2B
| – | – |
-3,980
| Closed | -$247K |
|
155
Take-Two Interactive
TTWO
$47.4B
| – | – |
-1,730
| Closed | -$206K |
|
156
Uber
UBER
$159B
| – | – |
-7,530
| Closed | -$239K |
|
|
VTYX
157
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-23,583
| Closed | -$790K |
|
158
Workday
WDAY
$45.5B
| – | – |
-1,760
| Closed | -$364K |
|
|
X
159
DELISTED
US Steel
X
| – | – |
-8,280
| Closed | -$216K |
|
|
EDR
160
DELISTED
Endeavor Group Holdings, Inc.
EDR
| – | – |
-19,160
| Closed | -$458K |
|
|
BLU
161
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-68,292
| Closed | -$492K |
|
|
RXDX
162
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-20,955
| Closed | -$2.25M |
|
|
OSH
163
DELISTED
Oak Street Health, Inc.
OSH
| – | – |
-89,400
| Closed | -$3.46M |
|
Similar funds
SIAG
MS
WI
WTFG
VIA
A6
PI
ACM
HighVista Strategies's Q2 2023 Portfolio in Review
As of Q2 2023, HighVista Strategies held 163 positions worth $219M, up 78% from $123M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
HighVista Strategies deployed $80.7M of net new capital in Q2 2023, opening 55 new positions and adding to 48 existing holdings. Its largest new stake was Aerojet Rocketdyne Holdings: 61,520 shares worth $3.38M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 67% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Travere Therapeutics, an estimated $1.75M trimmed.
- HighVista Strategies's largest Q2 2023 buy was Aerojet Rocketdyne Holdings: 61,520 shares worth $3.38M.
- HighVista Strategies added most to Invesco DB Commodity Index Tracking Fund in Q2 2023, an estimated $32.3M increase.
- HighVista Strategies's biggest Q2 2023 reduction was Travere Therapeutics, cutting an estimated $1.75M.
- HighVista Strategies fully exited iShares Russell 1000 Value ETF in Q2 2023, selling an estimated $4.25M.
- HighVista Strategies's ten largest holdings make up 34% of its $219M portfolio in Q2 2023.
- HighVista Strategies opened 55 new positions and closed 29 in Q2 2023.
- HighVista Strategies's portfolio value rose 78% quarter-over-quarter to $219M.
Based on HighVista Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.